The Wnt pathway destabilizes adherens junctions and promotes cell migration via β-catenin and its target gene cyclin D1

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 26-31

  Vlad Fiegen, Annica ^a   Langerak, Anette ^b   Eberth, Sonja ^c   Müller, Oliver ^d  

^a GERMAN AEROSPACE CENTER DLR   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^c LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^d UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

Author keywords

Catenin; Adherens junction; Cell migration; Cyclin D1; Wnt pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; UVOMORULIN; WNT PROTEIN;

ACTIN FILAMENT; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL ASSAY; CELL CONTACT; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MACROPHAGE MIGRATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84861211614     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.02.004     Document Type: Article

References (46)

1. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 2003, 1653(1):1-24.
2. Daniels D.L., Weis W.I. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 2005, 12(4):364-371.
3. Brembeck F.H., Rosario M., Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 2006, 16(1):51-59.
4. Yamada S., Pokutta S., Drees F., Weis W.I., Nelson W.J. Deconstructing the cadherin-catenin-actin complex. Cell 2005, 123(5):889-901.
5. Drees F., Pokutta S., Yamada S., Nelson W.J., Weis W.I. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 2005, 123(5):903-915.
6. Pokutta S., Weis W.I. Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu. Rev. Cell Dev. Biol. 2007, 23:237-261.
7. Brabletz T., Jung A., Reu S., et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA 2001, 98(18):10356-10361.
8. Behrens J., Mareel M.M., Van Roy F.M., Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 1989, 108(6):2435-2447.
9. Vleminckx K., Vakaet L., Mareel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991, 66(1):107-119.
10. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res. Treat. 1993, 24(3):175-184.
11. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392(6672):190-193.
12. Orsulic S., Huber O., Aberle H., Arnold S., Kemler R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J. Cell Sci. 1999, 112(Pt 8):1237-1245.
13. Stockinger A., Eger A., Wolf J., Beug H., Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J. Cell Biol. 2001, 154(6):1185-1196.
14. Gottardi C.J., Wong E., Gumbiner B.M. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 2001, 153(5):1049-1060.
15. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2(6):442-454.
16. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4(12):915-925.
17. Lilien J., Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 2005, 17(5):459-465.
18. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398(6726):422-426.
19. Shtutman M., Zhurinsky J., Simcha I., et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 1999, 96(10):5522-5527.
20. Willert J., Epping M., Pollack J.R., Brown P.O., Nusse R. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol. 2002, 2(1):8.
21. van De W.M., Sancho E., Verweij C., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111(2):241-250.
22. Sansom O.J., Reed K.R., Hayes A.J., et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004, 18(12):1385-1390.
23. Andreu P., Colnot S., Godard C., et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development 2005, 132(6):1443-1451.
24. Morgan D.O. Principles of CDK regulation. Nature 1995, 374(6518):131-134.
25. Matsushime H., Roussel M.F., Sherr C.J. Novel mammalian cyclins (CYL genes) expressed during G1. Cold Spring Harb. Symp. Quant. Biol. 1991, 56:69-74.
26. Motokura T., Bloom T., Kim H.G., et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991, 350(6318):512-515.
27. Xiong Y., Beach D. Population explosion in the cyclin family. Curr. Biol. 1991, 1(6):362-364.
28. Coqueret O. Linking cyclins to transcriptional control. Gene 2002, 299(1-2):35-55.
29. Opitz O.G., Rustgi A.K. Interaction between Sp1 and cell cycle regulatory proteins is important in transactivation of a differentiation-related gene. Cancer Res. 2000, 60(11):2825-2830.
30. Inoue K., Sherr C.J. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol. Cell Biol. 1998, 18(3):1590-1600.
31. Knudsen K.E., Cavenee W.K., Arden K.C. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res. 1999, 59(10):2297-2301.
32. Petre C.E., Wetherill Y.B., Danielsen M., Knudsen K.E. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J. Biol. Chem. 2002, 277(3):2207-2215.
33. Wang C., Pattabiraman N., Zhou J.N., et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol. Cell Biol. 2003, 23(17):6159-6173.
34. Lin H.M., Zhao L., Cheng S.Y. Cyclin D1 is a ligand-independent co-repressor for thyroid hormone receptors. J. Biol. Chem. 2002, 277(32):28733-28741.
35. Neumeister P., Pixley F.J., Xiong Y., et al. Cyclin D1 governs adhesion and motility of macrophages. Mol. Biol. Cell 2003, 14(5):2005-2015.
36. Li Z., Wang C., Prendergast G.C., Pestell R.G. Cyclin D1 functions in cell migration. Cell Cycle 2006, 5(21):2440-2442.
37. Rubinfeld B., Robbins P., El Gamil M., et al. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997, 275(5307):1790-1792.
38. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA 1995, 92(7):3046-3050.
39. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279(5350):509-514.
40. Ananthakrishnan R., Ehrlicher A. The forces behind cell movement. Int. J. Biol. Sci. 2007, 3(5):303-317.
41. Bloom J., Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 2003, 13(1):41-47.
42. Slingerland J., Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 2000, 183(1):10-17.
43. Philipp-Staheli J., Payne S.R., Kemp C.J. P27(Kip1): regulation and function of a haplo insufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res. 2001, 264(1):148-168.
44. Besson A., Gurian-West M., Schmidt A., Hall A., Roberts J.M. P27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 2004, 18(8):862-876.
45. Lee S., Helfman D.M. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J. Biol. Chem. 2004, 279(3):1885-1891.
46. Yokoo T., Toyoshima H., Miura M., et al. P57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J. Biol. Chem. 2003, 278(52):52919-52923.